A severe de novo methylation of episomal vectors by human ES cells

Biochemical and Biophysical Research Communications

Volumn 349, Issue 4, 2006, Pages 1269-1277

  Kameda, Takashi ^a   Smuga Otto, Kim ^b   Thomson, James A ^a,b,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c WiCell Research Institute   (United States)

Author keywords

de novo CpG methylation; Episomal vectors; Epstein Barr virus (EBV); Human embryonic stem cells

Indexed keywords

DNA METHYLTRANSFERASE;

ARTICLE; CPG ISLAND; EMBRYONIC STEM CELL; EPIGENETICS; EPISOME; GENE SILENCING; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; METHYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELLS, CULTURED; DNA METHYLATION; GENETIC VECTORS; HERPESVIRUS 4, HUMAN; HUMANS; PLASMIDS; RECOMBINANT PROTEINS; STEM CELLS; TRANSFECTION;

HUMAN HERPESVIRUS 4;

EID: 33748777093     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.08.175     Document Type: Article

References (76)

1. Evans M.J., and Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292 (1981) 154-156
2. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 78 (1981) 7634-7638
3. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., and Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
4. Ginis I., Luo Y., Miura T., Thies S., Brandenberger R., Gerecht-Nir S., Amit M., Hoke A., Carpenter M.K., Itskovitz-Eldor J., and Rao M.S. Differences between human and mouse embryonic stem cells. Dev. Biol. 269 (2004) 360-380
5. Rao M. Conserved and divergent paths that regulate self-renewal in mouse and human embryonic stem cells. Dev. Biol. 275 (2004) 269-286
6. Kameda T., and Thomson J.A. Human ERas gene has an upstream premature polyadenylation signal that results in a truncated, non coding transcript. Stem Cells 23 (2005) 1535-1540
7. Eiges R., Schuldiner M., Drukker M., Yanuka O., Itskovitz-Eldor J., and Benvenisty N. Establishment of human embryonic stem-cell-transfected clones carrying a marker for undifferentiated cells. Curr. Biol. 11 (2001) 514-518
8. Lakshmipathy U., Pelacho B., Sudo K., Linehan J.L., Coucouvanis E., Kaufman D.S., and Verfaillie C.M. Efficient transfection of embryonic and adult stem cells. Stem Cells 22 (2004) 531-543
9. Zwaka T.P., and Thomson J.A. Homologous recombination in human embryonic stem cells. Nat. Biotechnol. 21 (2003) 319-321
10. Ma Y., Ramezani A., Lewis R., Hawley R.G., and Thomson J.A. High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells 21 (2003) 111-117
11. Margolskee R.F. Epstein-Barr virus based expression vectors. Curr. Top. Microbiol. Immunol. 158 (1992) 67-95
12. van Craenenbroeck K., Vanhoenacker P., and Haegeman G. Episomal vectors for gene expression in mammalian cells. Eur. J. Biochem. 267 (2000) 5665-5678
13. Leight E.R., and Sugden B. EBNA1: a protein pivotal to latent infection by Epstein-Barr virus. Rev. Med. Virol. 10 (2000) 83-100
14. Längle-Rouault F., Patzel V., Benavente A., Taillez M., Silvestre N., Bompard A., Sczakiel G., Jacobs E., and Rittner K. Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: implications of the nuclear import of plasmids. J. Virol. 72 (1998) 6181-6185
15. Leight E.R., and Sugden B. Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event. Mol. Cell. Biol. 21 (2001) 4149-4161
16. Ren C., Zhao M., Yang X., Li D., Jiang X., Wang L., Shan W., Yang H., Zhou L., Zhou W., and Zhang H. Establishment and application of Epstein-Barr virus-based episomal vectors in human embryonic stem cells. Stem Cells 24 (2006) 1338-1347
17. Amit M., Carpenter M.K., Inokuma M.S., Chiu C.P., Harris C.P., Waknitz M.A., Itskovitz-Eldor J., and Thomson J.A. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227 (2000) 271-278
18. Yu J., Vodyanik M.A., He P., Slukvin I.I., and Thomson J.A. Human embryonic stem cells reprogram myeloid precursors following cell-cell fusion. Stem Cells 24 (2006) 168-176
19. Nagai M., Nakamura A., Makino R., and Mitamura K. Expression of DNA (5-cytosin)-methyltransferases (DNMTs) in hepatocellular carcinomas. Hepatol. Res. 26 (2003) 186-191
20. Ramage A.D., Clark A.J., Smith A.G., Mountford P.S., and Burt D.W. Improved EBV-based shuttle vector system: dicistronic mRNA couples the synthesis of the Epstein-Barr nuclear antigen-1 protein to neomycin resistance. Gene 197 (1997) 83-89
21. Reisman D., Yates J., and Sugden B. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol. Cell. Biol. 5 (1985) 1822-1832
22. Tanaka J., Miwa Y., Miyoshi K., Ueno A., and Inoue H. Construction of Epstein-Barr virus-based expression vector containing mini-oriP. Biochem. Biophys. Res. Commun. 264 (1999) 938-943
23. Ziegler K., Bui T., Frisque R.J., Grandinetti A., and Nerurkar V.R. A rapid in vitro polyomavirus DNA replication assay. J. Virol. Methods 122 (2004) 123-127
24. Clark S.J., Harrison J., Paul C.L., and Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 22 (1994) 2990-2997
25. Kennedy G., Komano J., and Sugden B. Epstein-Barr virus provides a survival factor to Burkitt's lymphomas. Proc. Natl. Acad. Sci. USA 100 (2003) 14269-14274
26. Scholer H.R., Balling R., Hatzopoulo A.K., Suzuki N., and Gruss P. Octamer binding proteins confer transcriptional activity in early mouse embryogenesis. EMBO J. 8 (1989) 2551-2557
27. Nichols J., Zevnik B., Anastassiadis K., Niwa H., Klewe-Nebenius D., Chambers I., Scholer H., and Smith A. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95 (1998) 379-391
28. Mitsui K., Tokuzawa Y., Itoh H., Segawa K., Murakami M., Takahashi K., Maruyama M., Maeda M., and Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113 (2003) 631-642
29. Chambers I., Colby D., Robertson M., Nichols J., Lee S., Tweedie S., and Smith A. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113 (2003) 643-655
30. Turek-Plewa J., and Jagodzi'nski P.P. The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell. Mol. Biol. Lett. 10 (2005) 631-647
31. Klose R.J., and Bird A.P. Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci. 31 (2006) 89-97
32. Turker M.S. Gene silencing in mammalian cells and spread of DNA methylation. Oncogene 21 (2002) 5388-5393
33. Robertson K.D. DNA methylation and chromatin-unraveling the tangled web. Oncogene 21 (2002) 5361-5379
34. Okano M., Bell D.W., Haber D.A., and Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99 (1999) 247-257
35. Jackson M., Krassowska A., Gilbert N., Chevassut T., Forrester L., Ansell J., and Ramsahoye B. Severe global DNA hypomethylation blocks differentiation and induces histon hyperacetylation in embryonic stem cells. Mol. Cell. Biol. 24 (2004) 8862-8871
36. Sperger J.M., Chen X., Draper J.S., Antosiewicz J.E., Chon C.H., Jones S.B., Brooks J.D., Andrews P.W., Brown P.O., and Thomson J.A. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc. Natl. Acad. Sci. USA 100 (2003) 13350-13355
37. Richards M., Tan S.P., Tan J.H., Chan W.K., and Bongso A. The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells 22 (2004) 51-64
38. Bhattacharya B., Miura T., Brandenberger R., Mejido J., Luo Y., Yang A.X., Joshi B.H., Ginis J., Thies R.S., Amit M., Lyons I., Condie B.G., Itskovitz-Eldor J., Rao M.S., and Puri R.K. Gene expression in human embryonic stem cell lines: unique molecular signature. Blood 103 (2004) 2956-2964
39. Han L., Lin I.G., and Hsieh C.L. Protein binding protects sites on stable episomes and in the chromosome from de novo methylation. Mol. Cell. Biol. 21 (2001) 3416-3424
40. Grant S.G., and Chapman V.M. Mechanism of X-chromosome regulation. Ann. Rev. Genet. 22 (1988) 199-233
41. Tollefesbol T.O., and Hutchison III C.A. Control of methylation spreading in synthetic DNA sequences by the murine DNA methyltransferase. J. Mol. Biol. 269 (1997) 494-504
42. Turker M.S. Gene silencing in mammalian cells and the spread of DNA methylation. Oncogene 21 (2002) 5388-5393
43. Falk K.I., Szekely L., Aleman A., and Ernberg I. Specific methylation patterns in two control region of Epstein-Barr virus latency: the LMP-1-coding upstream regulatory region and an origin of DNA replication (oriP). J. Virol. 72 (1998) 2969-2974
44. Tao Q., and Robertson K.D. Stealth technology: how Epstein-Barr virus utilizes DNA methylation to cloak it self from immune detection. Clin. Immunol. 109 (2003) 53-63
45. Grant M., Zuccotti M., and Monk M. Methylation of CpG sites of X-linked genes coincides with X-inactivation in the female mouse embryo but not in the germ line. Nat. Genet. 2 (1992) 161-166
46. Pfeifer G.P., and Riggs A.D. Chromatin differences between active and inactive X chromosomes revealed by genomic footprinting of permialized cells using Dnase I and ligation-mediated PCR. Genes Dev. 5 (1991) 1102-1113
47. Tommasi S., LeBon J.M., Riggs A.D., and Singer-Sam J. Methylation analysis by genomic sequencing of 5′ region of mouse Pgk-1 gene and a cautionary note concerning the method. Somatic Cell Mol. Genet. 19 (1993) 529-541
48. Dhara S.K., and Benvenisty N. Gene trap as a tool for genome annotation and analysis of X chromosome inactivation in human embryonic stem cells. Nucleic Acids Res. 32 (2004) 3995-4002
49. Hoffman L.M., Batten J.L., Young H., Pardasani D., Baetge E.E., Lawrence J., and Carpenter M.K. X-inactivation status varies in human embryonic stem cell lines. Stem Cells 23 (2005) 1468-1478
50. Ramsahoye B.H., Biniszkiewicz D., Lyko F., Clark V., Bird A.P., and Jaenisch R. Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc. Natl. Acad. Sci. USA 97 (2000) 5237-5242
51. Aoki A., Suetake I., Miyagawa J., Fujio T., Chijima T., Sasaki H., and Tajima S. Enzymatic properties of de novo-type mouse DNA (cytosine-5) methyltransferases. Nucleic Acids Res. 29 (2001) 3506-3512
52. Gowher H., and Jeltsch A. Enzymatic properties of recombinant Dnmt3a DNA methyltransferase from mouse: the enzyme modifies DNA in a non-processive manner and also methylates non-CpG sites. J. Mol. Biol. 309 (2001) 1201-1208
53. Dodge J.E., Ramsahoye B.H., Wo Z.G., Okano M., and Li E. De novo methylation of MMLV provirus in embryonic stem cells: CpG versus non-CpG methylation. Gene 289 (2002) 41-48
54. Schroeder M., and Mass M.J. CpG methylation inactivates the transcriptional activity of the promoter of the human p53 tumor suppressor gene. Biochem. Biophys. Res. Commun. 235 (1997) 403-406
55. Robertson K.D., and Ambinder R.F. Mapping promoter regions that are hypersensitive to methylation-mediated inhibition of transcription: application of the methylation cassette assay to the Epstein-Barr virus major latency promoter. J. Virol. 71 (1997) 6445-6454
56. Ortmann C.A., Burchert A., Hölzle K., Nitsche A., Wittig B., Neubauer A., and Schmidt M. Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter region. Nucleic Acids Res. 33 (2005) 6895-6905
57. Oka M., Meacham A.M., Hamazaki T., Rodic N., Chang L.J., and Terada N. De novo DNA methyltransferases Dnmt3a and Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2′-deoxycytidine. Oncogene 24 (2005) 3091-3099
58. Stuhlmann H., Jahner D., and Jaenisch R. Infectivity and methylation of retroviral genomes is correlated with expression in the animal. Cell 26 (1981) 221-232
59. Jahner D., Stuhlmann H., Stewart C.L., Harbers K., Lohler J., Simon J., and Jaenisch R. De novo methylation and expression of retroviral genomes during mouse embryogenesis. Nature 298 (1982) 623-628
60. Stewart C.L., Stuhlmann H., Jähner D., and Jaenisch R. De novo methylation, expression, and infectivity of retroviral genomes introduced into embryonal carcinoma cells. Proc. Natl. Acad. Sci. USA 79 (1982) 4098-4102
61. Challita P.M., and Kohn D.B. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc. Natl. Acad. Sci. USA 91 (1994) 2567-2571
62. Gautsch J.W., and Wilson M.C. Delayed de novo methylation in teratocarcinoma suggests additional tissue-specific mechanisms for controlling gene expression. Nature 301 (1983) 32-37
63. Niwa O., Yokota Y., Ishida H., and Sugihara T. Independent mechanisms involved in suppression of the Molony leukemia virus genome during differentiation of murine teratocarcinoma cells. Cell 32 (1983) 1105-1113
64. Pannell D., Osborne C.S., Yao S., Sukonnik T., Pasceri P., Karaskakis A., Okano M., Li E., Lipshitz H.D., and Ellis J. Retrovirus silencing is de novo methylase independent and marked by a repressive histone code. EMBO J. 19 (2000) 5884-5894
65. Yoder J.A., Walsh C.P., and Bestor T.H. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 13 (1997) 335-340
66. Lin I.G., Han L., Taghva A., O'Brien L.E., and Hsieh C.L. Murine de novo methyltransferase Dnmt3a demonstrates strand asymmetry and site preference in the methylation of DNA in vitro. Mol. Cell. Biol. 22 (2002) 704-723
67. Yokochi T., and Robertson K.D. Preferential methylation of unmethylated DNA by mammalian de novo DNA methyltransferase Dnmt3a. J. Biol. Chem. 277 (2002) 11735-11745
68. Suetake I., Miyazaki J., Murakami C., Takeshima H., and Tajima S. Distinct enzymatic properties of recombinant mouse DNA methyltransferases Dnmt3a and Dnmt3b. J. Biochem. 133 (2003) 737-744
69. Lorincz M.C., Schubeler D., and Groudine M. Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation. Mol. Cell. Biol. 21 (2001) 7913-7922
70. He J., Yang Q., and Chang L.J. Dynamic DNA methylation and histon modifications contribute to lentiviral transgene silencing in murine embryonic carcinoma cells. J. Virol. 79 (2005) 13497-13508
71. Hsieh C.L. In vivo activity of murine de novo methyltransferases, Dnmt3a and Dnmt3b. Mol. Cell. Biol. 19 (1999) 8211-8218
72. Tao Q., Huang H., Geiman T.M., Lim C.Y., Fu L., Qiu G.H., and Robertson K.D. Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells. Hum. Mol. Genet. 11 (2002) 2091-2102
73. Yoshioka M., Kikuta H., Ishiguro N., Endo R., and Kobayashi K. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome. J. Med. Virol. 70 (2003) 410-419
74. Li H., and Minarovits J. Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation. Adv. Cancer Res. 89 (2003) 133-156
75. Chau C.M., and Lieberman P.M. Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus. J. Virol. 78 (2004) 12308-12319
76. Yoshioka M., Ishiguro N., Ishiko H., Ma X., Kikuta H., and Kobayashi K. Heterogeneous, restricted patterns of Epstein-Barr virus (EBV) latent gene expression in patients with chronic active EBV infection. J. Gen. Virol. 82 (2001) 2385-2392